HI
KYNB icon

HBK Investments’s Kyntra Bio KYNB Stock Holding History

HBK Investments’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,452
Closed -$1.97M – 762
2019
Q1 		$1.97M Buy
+1,452
New +$1.97M 0.02% 524
2018
Q2 		– Sell
-1,744
Closed -$2.01M – 1068
2018
Q1 		$2.01M Buy
1,744
+52
+3% +$68.5K 0.01% 447
2017
Q4 		$2M Sell
1,692
-596
-26% -$747K 0.02% 448
2017
Q3 		$3.08M Buy
2,288
+179
+8% +$189K 0.02% 358
2017
Q2 		$1.7M Buy
2,109
+1,173
+125% +$817K 0.01% 451
2017
Q1 		$577K Buy
+936
New +$570K ﹤0.01% 491
2016
Q3 		– Sell
-4,626
Closed -$1.9M – 877
2016
Q2 		$1.9M Buy
4,626
+3,634
+366% +$1.66M 0.01% 439
2016
Q1 		$528K Buy
+992
New +$494K 0.01% 720

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments's KYNB Position: Q2 2019 in Review

HBK Investments sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 1,452 shares — an estimated $1.97M sold.

HBK Investments first reported a position in KYNB in Q1 2016 and held it in 8 quarters. The position peaked at $3.08M in Q3 2017. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • HBK Investments reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 1,452 Kyntra Bio shares in Q2 2019, an estimated $1.97M.
  • HBK Investments first reported a position in Kyntra Bio in Q1 2016 and held it in 8 quarters.
  • HBK Investments's Kyntra Bio position peaked at $3.08M in Q3 2017.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.